Rajiv De Silva
Rajiv De Silva has announced that he will quit as president and CEO of speciality pharmaceuticals for Valeant.
Of the matter, the firm said only that he wishes to “pursue other interests”.
De Silva will remain with the company until the end of the year to ensure integration efforts following the recent acquisition of Medicis go smoothly.
Michael Pearson, chairman and CEO said: "Although his leadership will be missed, the company has created and developed a strong management team with Rajiv's assistance that I am confident will lead us successfully through this transition period and into the future."